Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mack Roach

Showing results (201-210 of 284) with videos related to

Pageof 29
Sort By:
International Journal of Radiation Oncology, Biology, Physics|July 28, 2009
Functional interference clusters in cancer patients with bone metastases: a secondary analysis of RTOG 9714Edward Chow, Jennifer James, Andrea Barsevick, et al.
Journal of Palliative Medicine|July 1, 2008
Can physicians accurately predict survival time in patients with metastatic cancer? Analysis of RTOG 97-14William F Hartsell, Michelle Desilvio, Deborah Watkins Bruner, et al.
The Journal of Urology|May 19, 2015
Patterns of Local Failure following Radiation Therapy for Prostate CancerMohamed Jalloh, Michael S Leapman, Janet E Cowan, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2007
Racial differences in CYP3A4 genotype and survival among men treated on Radiation Therapy Oncology Group (RTOG) 9202: a phase III randomized trialMack Roach, Michelle De Silvio, Timothy Rebbick, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2008
Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapyNelson N Stone, Louis Potters, Brian J Davis, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 2021
Stereotactic Body Radiation Therapy and High-Dose-Rate Brachytherapy Boost in Combination With Intensity Modulated Radiation Therapy for Localized Prostate Cancer: A Single-Institution Propensity Score Matched AnalysisWilliam C Chen, Yun Li, Ann Lazar, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Postoperative nomogram predicting the 9-year probability of prostate cancer recurrence after permanent prostate brachytherapy using radiation dose as a prognostic variableLouis Potters, Mack Roach, Brian J Davis, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 26, 2002
Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesotheliomaTerry T Lee, Darcie L Everett, Hui-Kuo G Shu, et al.
Seminars in Radiation Oncology|March 28, 2002
Trade-off to low-grade toxicity with conformal radiation therapy for prostate cancer on Radiation Therapy Oncology Group 9406Jeff M Michalski, Kathryn Winter, James A Purdy, et al.
International Journal of Radiation Oncology, Biology, Physics|July 13, 2013
Adjuvant and salvage radiation therapy after prostatectomy: American Society for Radiation Oncology/American Urological Association guidelinesRichard K Valicenti, Ian Thompson, Peter Albertsen, et al.
Pageof 29

Showing results (201-210 of 284) with videos related to

Sort By:
Pageof 29
International Journal of Radiation Oncology, Biology, Physics|July 28, 2009
Functional interference clusters in cancer patients with bone metastases: a secondary analysis of RTOG 9714Edward Chow, Jennifer James, Andrea Barsevick, et al.
Journal of Palliative Medicine|July 1, 2008
Can physicians accurately predict survival time in patients with metastatic cancer? Analysis of RTOG 97-14William F Hartsell, Michelle Desilvio, Deborah Watkins Bruner, et al.
The Journal of Urology|May 19, 2015
Patterns of Local Failure following Radiation Therapy for Prostate CancerMohamed Jalloh, Michael S Leapman, Janet E Cowan, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2007
Racial differences in CYP3A4 genotype and survival among men treated on Radiation Therapy Oncology Group (RTOG) 9202: a phase III randomized trialMack Roach, Michelle De Silvio, Timothy Rebbick, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2008
Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapyNelson N Stone, Louis Potters, Brian J Davis, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 2021
Stereotactic Body Radiation Therapy and High-Dose-Rate Brachytherapy Boost in Combination With Intensity Modulated Radiation Therapy for Localized Prostate Cancer: A Single-Institution Propensity Score Matched AnalysisWilliam C Chen, Yun Li, Ann Lazar, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Postoperative nomogram predicting the 9-year probability of prostate cancer recurrence after permanent prostate brachytherapy using radiation dose as a prognostic variableLouis Potters, Mack Roach, Brian J Davis, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 26, 2002
Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesotheliomaTerry T Lee, Darcie L Everett, Hui-Kuo G Shu, et al.
Seminars in Radiation Oncology|March 28, 2002
Trade-off to low-grade toxicity with conformal radiation therapy for prostate cancer on Radiation Therapy Oncology Group 9406Jeff M Michalski, Kathryn Winter, James A Purdy, et al.
International Journal of Radiation Oncology, Biology, Physics|July 13, 2013
Adjuvant and salvage radiation therapy after prostatectomy: American Society for Radiation Oncology/American Urological Association guidelinesRichard K Valicenti, Ian Thompson, Peter Albertsen, et al.
Pageof 29